Copyright
©The Author(s) 2021.
World J Clin Oncol. Feb 24, 2021; 12(2): 103-114
Published online Feb 24, 2021. doi: 10.5306/wjco.v12.i2.103
Published online Feb 24, 2021. doi: 10.5306/wjco.v12.i2.103
Figure 1 Kaplan-Meier curves.
Progression free survival (A) and overall survival (B) of immune-related adverse events vs no immune-related adverse events using Kaplan-Meier methods with log-rank test for P value. irAE: Immune-related adverse events.
- Citation: Peravali M, Gomes-Lima C, Tefera E, Baker M, Sherchan M, Farid S, Burman K, Constantinescu F, Veytsman I. Racial disparities in immune-related adverse events of immune checkpoint inhibitors and association with survival based on clinical and biochemical responses. World J Clin Oncol 2021; 12(2): 103-114
- URL: https://www.wjgnet.com/2218-4333/full/v12/i2/103.htm
- DOI: https://dx.doi.org/10.5306/wjco.v12.i2.103